Meningitis Vaccine Developer Lands $110M In Funding Round
A biopharmaceutical company developing a vaccine to prevent infections such as meningitis and pneumonia said Thursday it had closed on a $110 million funding round....To view the full article, register now.
Already a subscriber? Click here to view full article